Net Clinical Benefit of Prehospital Glycoprotein IIb/IIIa Inhibitors in Patients with ST-Elevation Myocardial Infarction and High Risk of Bleeding: Effect of Tirofiban in Patients at High Risk of Bleeding Using CRUSADE Bleeding Score

Author(s): 

Renicus S. Hermanides, MD1, Jan Paul Ottervanger, MD, PhD1, Jurrien M. ten Berg, MD, PhD2, 
A.T. Marcel Gosselink, MD, PhD1, Gert van Houwelingen, MD3, Jan-Henk E. Dambrink, MD, PhD1,
Pieter R. Stella, MD, PhD4, Christian Hamm, MD, PhD5, Arnoud W.J. van ’t Hof, MD, PhD1, on behalf of the On-TIME 2 Trial Investigators

Bookmark/Search this post with
image description image description Other Original Contribution Articles




  


  
Post new comment


  



 
 




 
 




 
 



  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
More information about formatting options





Image CAPTCHA

 
 
 
Enter the characters shown in the image.